EVIDENCE FOR THE INVOLVEMENT OF CENTRAL 5-HT1A RECEPTORS IN THE MEDIATION OF LORDOSIS BEHAVIOR IN THE FEMALE RAT

被引：20

作者：

AHLENIUS, S

LARSSON, K

FERNANDEZGUASTI, A

机构：

[1] INST MEXICANO PSIQUIAT,DIV INVEST NEUROCIENCIAS,MEXICO CITY 14000,DF,MEXICO

[2] GOTHENBURG UNIV,DEPT PSYCHOL,PSYCHOBIOL UNIT,S-40220 GOTHENBURG,SWEDEN

[3] CTR INVEST ESTUDIOS AVANZADOS,INST POLYTECT NACL,DEPT FARMACO & TOXICOL,SECC TERAPEUT EXPTL,MEXICO CITY 14000,DF,MEXICO

来源：

PSYCHOPHARMACOLOGY | 1989年 / 98卷 / 04期

关键词：

D O I：

10.1007/BF00441938

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：440 / 444

页数：5

相关论文

共 35 条

[21] A FACILITATORY ROLE FOR SEROTONIN IN THE SEXUAL-BEHAVIOR OF THE FEMALE RAT
MENDELSON, SD
GORZALKA, BB
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 22 (06) : 1025 - 1033
[22] SEROTONIN SYNTHESIS INHIBITION AND ESTROUS BEHAVIOR IN FEMALE RATS
MEYERSON, BJ
LEWANDER, T
[J]. LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1970, 9 (12): : 661 - &
[23] MEYERSON BJ, 1978, BIOL DETERMINANTS SE, P521
[24] DIRECT EVIDENCE FOR AN INTERACTION OF BETA-ADRENERGIC BLOCKERS WITH 5-HT RECEPTOR
MIDDLEMISS, DN
BLAKEBOROUGH, L
LEATHER, SR
[J]. NATURE, 1977, 267 (5608) : 289 - 290
[25] 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)-TETRALIN DISCRIMINATES BETWEEN SUBTYPES OF THE 5-HT1 RECOGNITION SITE
MIDDLEMISS, DN
FOZARD, JR
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 90 (01) : 151 - 153
[26] BLOCKADE OF CENTRAL 5-HYDROXYTRYPTAMINE RECEPTORS BY METHIOTHEPIN
MONACHON, MA
JALFRE, M
BURKARD, WP
HAEFELY, W
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1972, 274 (02) : 192 - &
[27] NAHORSKI SR, 1983, BRIT J PHARMACOL, V78, pP107
[28] DISCRIMINATION OF MULTIPLE [H-3]5-HYDROXYTRYPTAMINE BINDING-SITES BY THE NEUROLEPTIC SPIPERONE IN RAT-BRAIN
PEDIGO, NW
YAMAMURA, HI
NELSON, DL
[J]. JOURNAL OF NEUROCHEMISTRY, 1981, 36 (01) : 220 - 226
[29] 5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES - MOLECULAR, BIOCHEMICAL AND PHYSIOLOGICAL CHARACTERIZATION
PEROUTKA, SJ
[J]. TRENDS IN NEUROSCIENCES, 1988, 11 (11) : 496 - 500
[30] PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687

← 1 2 3 4 →